- Home
- FSUN vs QURE Comparison
FSUN vs QURE Comparison
Compare FSUN & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSUN
- QURE
- Stock Information
- Founded
- FSUN 1892
- QURE 1998
- Country
- FSUN United States
- QURE Netherlands
- Employees
- FSUN 1168
- QURE N/A
- Industry
- FSUN Major Banks
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- FSUN Finance
- QURE Health Care
- Exchange
- FSUN Nasdaq
- QURE Nasdaq
- Market Cap
- FSUN 1.1B
- QURE 866.3M
- IPO Year
- FSUN N/A
- QURE 2007
- Fundamental
- Price
- FSUN $38.56
- QURE $59.63
- Analyst Decision
- FSUN Buy
- QURE Strong Buy
- Analyst Count
- FSUN 3
- QURE 12
- Target Price
- FSUN $47.33
- QURE $69.67
- AVG Volume (30 Days)
- FSUN 150.4K
- QURE 7.7M
- Earning Date
- FSUN 11-27-2025
- QURE 11-04-2025
- Dividend Yield
- FSUN N/A
- QURE N/A
- EPS Growth
- FSUN N/A
- QURE N/A
- EPS
- FSUN 3.14
- QURE N/A
- Revenue
- FSUN $380,544,000.00
- QURE $14,337,000.00
- Revenue This Year
- FSUN $18.47
- QURE N/A
- Revenue Next Year
- FSUN $5.88
- QURE $287.72
- P/E Ratio
- FSUN $13.00
- QURE N/A
- Revenue Growth
- FSUN 10.96
- QURE N/A
- 52 Week Low
- FSUN $31.70
- QURE $5.35
- 52 Week High
- FSUN $45.32
- QURE $65.14
- Technical
- Relative Strength Index (RSI)
- FSUN 46.04
- QURE 67.93
- Support Level
- FSUN $37.65
- QURE $58.12
- Resistance Level
- FSUN $42.00
- QURE $65.14
- Average True Range (ATR)
- FSUN 1.49
- QURE 4.20
- MACD
- FSUN -0.22
- QURE -0.70
- Stochastic Oscillator
- FSUN 21.15
- QURE 60.08
About FSUN FirstSun Capital Bancorp
Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments - Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.